Kevin Doe's Blog (244)

The “Encapsulated Cell Therapies and Encapsulation Technologies Market”

To order this 500+ page report, please visit this https://www.rootsanalysis.com/reports/249/request-sample.html

Key Inclusions

 A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administration, along with information…

Continue

Added by Kevin Doe on March 9, 2021 at 5:27am — No Comments

The encapsulated cell therapies and encapsulation technologies market

Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this https://www.rootsanalysis.com/reports/249/request-sample.html

Key Market Insights

…

Continue

Added by Kevin Doe on March 9, 2021 at 5:26am — No Comments

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities

To order this 320+ page report, which features 120+ figures and 115+ tables, please visit this https://www.rootsanalysis.com/reports/297/request-sample.html

Key Market Insights

 Over 180 companies from different regions…

Continue

Added by Kevin Doe on March 8, 2021 at 3:04am — No Comments

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030

To order this 370+ page report, which features 190+ figures and 180+ tables, please visit this https://www.rootsanalysis.com/reports/253/request-sample.html

Key Market Insights

 Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain

 Presently, close to 50…

Continue

Added by Kevin Doe on March 8, 2021 at 3:04am — No Comments

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030”

The report features an extensive study of the current market landscape, offering an informed…

Continue

Added by Kevin Doe on March 8, 2021 at 3:04am — No Comments

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”

The report features an extensive study of the current landscape and…

Continue

Added by Kevin Doe on March 8, 2021 at 3:03am — No Comments

The ‘Blood-Brain Barrier (BBB) Market, 2020-2030

To order this detailed 400+ page report, please visit this https://www.rootsanalysis.com/reports/310/request-sample.html

Key Inclusions

 An overview of the overall landscape of BBB penetration technologies, featuring an in-depth analysis of the technologies based on a number of parameters, such as status of development (developed and under development), affiliated approach, type of compatible…

Continue

Added by Kevin Doe on March 5, 2021 at 3:17am — No Comments

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders

The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.

To order this 400+ page report, which features 145+ figures and 205+ tables, please visit this…

Continue

Added by Kevin Doe on March 5, 2021 at 3:16am — No Comments

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics.”

The…

Continue

Added by Kevin Doe on March 5, 2021 at 3:16am — No Comments

With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline

With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.

To order this 370+ page report, which features 90+ figures and 110+ tables, please…

Continue

Added by Kevin Doe on March 5, 2021 at 3:15am — No Comments

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this https://www.rootsanalysis.com/reports/286/request-sample.html

Key Market Insights

 With two…

Continue

Added by Kevin Doe on March 5, 2021 at 3:15am — No Comments

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services

Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations. Consequently, a number of drug manufacturers have demonstrated a preference for outsourcing fill / finish operations of such products.

To order this 480+ page report, which features 350+ figures and 260+ tables, please visit this…

Continue

Added by Kevin Doe on March 4, 2021 at 7:12am — No Comments

The contract fill / finish services market for biologics market

Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 480+ page report, which features 237 figures and 267 tables, please visit this https://www.rootsanalysis.com/reports/256/request-sample.html

Key Market Insights

 Over 115 companies…

Continue

Added by Kevin Doe on March 4, 2021 at 7:12am — No Comments

The contract fill / finish services market for biologics

A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”

The report features an extensive study on the contract service providers offering drug product manufacturing services within the…

Continue

Added by Kevin Doe on March 4, 2021 at 7:11am — No Comments

The biopharmaceutical contract manufacturing market

Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this https://www.rootsanalysis.com/reports/250/request-sample.html

Key Market Insights

 Over…

Continue

Added by Kevin Doe on March 4, 2021 at 7:11am — No Comments

Over 235 companies worldwide claim to offer contract manufacturing services

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel biologics that have specific manufacturing requirements. The contemporary contract services market features a mix of large and small-sized CMOs and is characterized by multiple mergers and…

Continue

Added by Kevin Doe on March 4, 2021 at 7:11am — No Comments

The biopharmaceutical contract manufacturing market

Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages

Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030.”

The report features an extensive study on the contract service providers within the biopharmaceutical industry.…

Continue

Added by Kevin Doe on March 4, 2021 at 7:10am — No Comments

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”

The report features an extensive study of the current market landscape, offering an informed opinion…

Continue

Added by Kevin Doe on March 3, 2021 at 5:59am — No Comments

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this Antibody Drug Conjugates Market (5th Edition), 2019-2030.

Key Market Insights

 Eminent representatives from different biopharmaceutical companies confirm the sustained interest in ADC therapeutics,…

Continue

Added by Kevin Doe on March 3, 2021 at 5:59am — No Comments

Monthly Archives

2022

2021

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service